What are the major opportunities in the Lung Cancer Diagnostic And Screening market? What are the strategies for the Lung Cancer Diagnostic And Screening market?

For detailed insights on the major opportunities and strategies in the Lung Cancer Diagnostic And Screening market, Read More

How does the Lung Cancer Diagnostic And Screening market relate to the overall economy and other similar markets?

For detailed insights on Lung Cancer Diagnostic And Screening's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Lung Cancer Diagnostic And Screening market growth? SWOT analysis of the Lung Cancer Diagnostic And Screening market.

For detailed insights on the key dynamics influencing the Lung Cancer Diagnostic And Screening market growth and SWOT analysis of the Lung Cancer Diagnostic And Screening industry, Read More

Lung Cancer Diagnostic And Screening Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Lung Cancer Diagnostic And Screening Market Report 2026

Name: Lung Cancer Diagnostic And Screening Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product (Instruments, Consumables And Accessories), By Test (Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests), By Cancer Type (Non-Small Cell Lung Cancer, Small Cell Lung Cancer), By End User (Hospital, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Lung Cancer Diagnostic And Screening Market Overview

• Lung Cancer Diagnostic And Screening market size has reached to $2.56 billion in 2025

• Expected to grow to $4.04 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%

• Growth Driver: Surging Prevalence Of Lung Cancer Drives Expansion In The Lung Cancer Diagnostic And Screening Market

• Market Trend: Blood-Based Test To Provide Accessible And Convenient Lung Cancer Screening

• North America was the largest region in 2025.

What Is Covered Under Lung Cancer Diagnostic And Screening Market?

Lung cancer diagnosis and screening refers to using examinations and techniques to discover and identify lung cancer in people with the goal of early detection and precise diagnosis for efficient treatment planning. It is commonly used to treat squamous cell carcinomas, adenocarcinoma, and large cell carcinoma.

The main products of lung cancer diagnostics and screening are instruments, consumables, and accessories. An instrument refers to products that are used to read or analyze the results of a diagnostic product, and process samples for a diagnostic product. The various tests include biomarkers tests, imaging tests, biopsy, blood tests, and others used for various cancer types such as non-small cell lung cancer, and small cell lung cancer. These are used by various end-users such as hospitals, independent diagnostic laboratories, diagnostic imaging centers, cancer research institutes, and others.

Lung Cancer Diagnostic And Screening Market Global Report 2026 Market Report bar graph

What Is The Lung Cancer Diagnostic And Screening Market Size and Share 2026?

The lung cancer diagnostic and screening market size has grown strongly in recent years. It will grow from $2.56 billion in 2025 to $2.8 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to high prevalence of smoking-related lung cancer, widespread use of chest x-ray and ct imaging, increasing hospital-based diagnostic infrastructure, rising awareness of early lung cancer detection, growth of biopsy-based diagnostic confirmation.

What Is The Lung Cancer Diagnostic And Screening Market Growth Forecast?

The lung cancer diagnostic and screening market size is expected to see strong growth in the next few years. It will grow to $4.04 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to expansion of national lung cancer screening initiatives, increasing adoption of low-dose ct screening, growing demand for biomarker and blood-based tests, rising healthcare investments in oncology diagnostics, improved access to diagnostic imaging centers. Major trends in the forecast period include rising adoption of early lung cancer screening programs, growing use of advanced imaging and biomarker tests, increasing focus on high-risk population screening, expansion of non-invasive diagnostic techniques, rising integration of multimodal diagnostic pathways.

Book your 30 minutes free consultation with our research experts

Global Lung Cancer Diagnostic And Screening Market Segmentation

1) By Product: Instruments, Consumables And Accessories

2) By Test: Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests

3) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer

4) By End User: Hospital, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Users

Subsegments:

1) By Instruments: Imaging Devices, Biopsy Devices, Bronchoscopy Systems

2) By Consumables And Accessories: Biopsy Needles, Reagents And Assays, Imaging Contrast Agents, Sample Collection Kits

What Is The Driver Of The Lung Cancer Diagnostic And Screening Market?

The increasing prevalence of lung cancer is expected to propel the growth of the lung cancer diagnostic and screening market going forward. Lung cancer is a malignant disease with symptoms such as coughing, chest pain, and difficulty breathing that is defined by the unchecked proliferation of abnormal cells in the lung tissues. Lung cancer diagnosis and screening help lung cancer patients early diagnose the disease with various tests, including an incisional biopsy and a bronchoscopy. For instance, in January 2023, according to the American Cancer Society, a US-based government organization, in the United States, there were approximately 238,340 new cases of lung cancer (117,550 in men and 120,790 in women). Further, there were reportedly 127,070 deaths from lung cancer (67,160 in men and 59,910 in women). Therefore, the rise in the prevalence of lung cancer is driving the growth of the lung cancer diagnostic and screening industry.

Key Players In The Global Lung Cancer Diagnostic And Screening Market

Major companies operating in the lung cancer diagnostic and screening market are Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, Koninklijke Philips N.V., GE Healthcare Bio Sciences AB, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., Myriad Genetic Laboratories Inc., NeoGenomics Laboratories Inc., Canon Medical Systems Corporation, Oncimmune Holdings Plc, Riverain Technologies LLC, VisionGate, Foundation Medicine Inc., Biodesix, OncoCyte, Broncus Medical Inc.

Global Lung Cancer Diagnostic And Screening Market Trends and Insights

Major companies in the lung cancer diagnostic and screening market are focused on developing a blood-based test that utilizes machine learning, such as whole-genome machine learning, to provide accessible and convenient lung cancer screening and gain a competitive edge in the market. Whole-genome machine learning refers to the application of machine learning algorithms to analyze and interpret comprehensive sets of genetic information, encompassing an organism's entire genome. For instance, in October 2023, DELFI Diagnostics Inc., a US-based developer of accessible blood-based tests, launched FirstLook Lung, a blood test using whole-genome machine learning to analyze cell-free DNA fragments, enhancing lung cancer screening with a 99.7% NPV. The test, designed for routine blood work, identifies individuals with potential lung cancer, including early-stage disease. Addressing low LDCT screening uptake, the test aims to improve population health.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Lung Cancer Diagnostic And Screening Market?

In May 2025, Johnson & Johnson MedTech, the medical-technology division of Johnson & Johnson Private Limited, partnered with Qure.ai, an India-based artificial intelligence healthcare company, to enhance early detection of lung cancer in India through AI-powered screening. With this partnership, Johnson & Johnson MedTech and Qure.ai aim to deploy Qure.ai’s AI-driven imaging solutions across a network of hospitals to enable earlier detection of lung cancer nodules, improving chances of timely treatment and better patient outcomes. Qure.ai is an India-based company specializing in artificial-intelligence diagnostic tools for radiology and medical imaging.

Regional Outlook

North America was the largest region in the lung cancer diagnostic and screening market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Lung Cancer Diagnostic And Screening Market?

The lung cancer diagnosis and screening market consists of revenues earned by entities by providing positron emission tomography (PET) scanners, and bronchoscopy. The market value includes the value of related goods sold by the service provider or included within the service offering. The lung cancer diagnosis and screening market also includes sales of products such as liquid biopsy kits, molecular testing kits, and biopsy tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Lung Cancer Diagnostic And Screening Market Report 2026?

The lung cancer diagnostic and screening market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lung cancer diagnostic and screening industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Lung Cancer Diagnostic And Screening Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.8 billion
Revenue Forecast In 2035	$4.04 billion
Growth Rate	CAGR of 9.4% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product, Test, Cancer Type, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, Koninklijke Philips N.V., GE Healthcare Bio Sciences AB, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., Myriad Genetic Laboratories Inc., NeoGenomics Laboratories Inc., Canon Medical Systems Corporation, Oncimmune Holdings Plc, Riverain Technologies LLC, VisionGate, Foundation Medicine Inc., Biodesix, OncoCyte, Broncus Medical Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Lung Cancer Diagnostic And Screening Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Lung Cancer Diagnostic And Screening Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Lung Cancer Diagnostic And Screening Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Lung Cancer Diagnostic And Screening Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Rising Adoption Of Early Lung Cancer Screening Programs

4.2.2 Growing Use Of Advanced Imaging And Biomarker Tests

4.2.3 Increasing Focus On High-Risk Population Screening

4.2.4 Expansion Of Non-Invasive Diagnostic Techniques

4.2.5 Rising Integration Of Multimodal Diagnostic Pathways

5. Lung Cancer Diagnostic And Screening Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Independent Diagnostic Laboratories

5.3 Diagnostic Imaging Centers

5.4 Cancer Research Institutes

5.5 Specialty Oncology Diagnostic Centers

6. Lung Cancer Diagnostic And Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lung Cancer Diagnostic And Screening Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Lung Cancer Diagnostic And Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Lung Cancer Diagnostic And Screening Market Size, Comparisons And Growth Rate Analysis

7.3. Global Lung Cancer Diagnostic And Screening Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Lung Cancer Diagnostic And Screening Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lung Cancer Diagnostic And Screening Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lung Cancer Diagnostic And Screening Market Segmentation

9.1. Global Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Instruments, Consumables And Accessories

9.2. Global Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests

9.3. Global Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Non-Small Cell Lung Cancer, Small Cell Lung Cancer

9.4. Global Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Users

9.5. Global Lung Cancer Diagnostic And Screening Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Imaging Devices, Biopsy Devices, Bronchoscopy Systems

9.6. Global Lung Cancer Diagnostic And Screening Market, Sub-Segmentation Of Consumables And Accessories, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biopsy Needles, Reagents And Assays, Imaging Contrast Agents, Sample Collection Kits

10. Lung Cancer Diagnostic And Screening Market Regional And Country Analysis

10.1. Global Lung Cancer Diagnostic And Screening Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Lung Cancer Diagnostic And Screening Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lung Cancer Diagnostic And Screening Market

11.1. Asia-Pacific Lung Cancer Diagnostic And Screening Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lung Cancer Diagnostic And Screening Market

12.1. China Lung Cancer Diagnostic And Screening Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lung Cancer Diagnostic And Screening Market

13.1. India Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lung Cancer Diagnostic And Screening Market

14.1. Japan Lung Cancer Diagnostic And Screening Market Overview

14.2. Japan Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lung Cancer Diagnostic And Screening Market

15.1. Australia Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lung Cancer Diagnostic And Screening Market

16.1. Indonesia Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lung Cancer Diagnostic And Screening Market

17.1. South Korea Lung Cancer Diagnostic And Screening Market Overview

17.2. South Korea Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lung Cancer Diagnostic And Screening Market

18.1. Taiwan Lung Cancer Diagnostic And Screening Market Overview

18.2. Taiwan Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lung Cancer Diagnostic And Screening Market

19.1. South East Asia Lung Cancer Diagnostic And Screening Market Overview

19.2. South East Asia Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lung Cancer Diagnostic And Screening Market

20.1. Western Europe Lung Cancer Diagnostic And Screening Market Overview

20.2. Western Europe Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lung Cancer Diagnostic And Screening Market

21.1. UK Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lung Cancer Diagnostic And Screening Market

22.1. Germany Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lung Cancer Diagnostic And Screening Market

23.1. France Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lung Cancer Diagnostic And Screening Market

24.1. Italy Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lung Cancer Diagnostic And Screening Market

25.1. Spain Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lung Cancer Diagnostic And Screening Market

26.1. Eastern Europe Lung Cancer Diagnostic And Screening Market Overview

26.2. Eastern Europe Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lung Cancer Diagnostic And Screening Market

27.1. Russia Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lung Cancer Diagnostic And Screening Market

28.1. North America Lung Cancer Diagnostic And Screening Market Overview

28.2. North America Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lung Cancer Diagnostic And Screening Market

29.1. USA Lung Cancer Diagnostic And Screening Market Overview

29.2. USA Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lung Cancer Diagnostic And Screening Market

30.1. Canada Lung Cancer Diagnostic And Screening Market Overview

30.2. Canada Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lung Cancer Diagnostic And Screening Market

31.1. South America Lung Cancer Diagnostic And Screening Market Overview

31.2. South America Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lung Cancer Diagnostic And Screening Market

32.1. Brazil Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lung Cancer Diagnostic And Screening Market

33.1. Middle East Lung Cancer Diagnostic And Screening Market Overview

33.2. Middle East Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lung Cancer Diagnostic And Screening Market

34.1. Africa Lung Cancer Diagnostic And Screening Market Overview

34.2. Africa Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Segmentation By Test, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lung Cancer Diagnostic And Screening Market Regulatory and Investment Landscape

36. Lung Cancer Diagnostic And Screening Market Competitive Landscape And Company Profiles

36.1. Lung Cancer Diagnostic And Screening Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Lung Cancer Diagnostic And Screening Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Lung Cancer Diagnostic And Screening Market Company Profiles

36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis

36.3.5. FUJIFILM Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Lung Cancer Diagnostic And Screening Market Other Major And Innovative Companies

Koninklijke Philips N.V., GE Healthcare Bio Sciences AB, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., Myriad Genetic Laboratories Inc., NeoGenomics Laboratories Inc., Canon Medical Systems Corporation, Oncimmune Holdings Plc, Riverain Technologies LLC, VisionGate, Foundation Medicine Inc., Biodesix, OncoCyte

38. Global Lung Cancer Diagnostic And Screening Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lung Cancer Diagnostic And Screening Market

40. Lung Cancer Diagnostic And Screening Market High Potential Countries, Segments and Strategies

40.1 Lung Cancer Diagnostic And Screening Market In 2030 - Countries Offering Most New Opportunities

40.2 Lung Cancer Diagnostic And Screening Market In 2030 - Segments Offering Most New Opportunities

40.3 Lung Cancer Diagnostic And Screening Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Lung Cancer Diagnostic And Screening Market, Overview Of Key Products - Product Examples

Table 2: Global Lung Cancer Diagnostic And Screening Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Lung Cancer Diagnostic And Screening Market, Supply Chain Analysis

Table 4: Global Lung Cancer Diagnostic And Screening Market, Major Raw Material Providers

Table 5: Global Lung Cancer Diagnostic And Screening Market, Major Resource Providers

Table 6: Global Lung Cancer Diagnostic And Screening Market, Major Manufacturers (Suppliers)

Table 7: Global Lung Cancer Diagnostic And Screening Market, Major Distributors And Channel Partners

Table 8: Global Lung Cancer Diagnostic And Screening Market, Key Technologies & Future Trends

Table 9: Global Lung Cancer Diagnostic And Screening Market, Major Trends

Table 10: Global Lung Cancer Diagnostic And Screening Market, Major End Users

Table 11: Global Lung Cancer Diagnostic And Screening Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Lung Cancer Diagnostic And Screening Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Lung Cancer Diagnostic And Screening Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Lung Cancer Diagnostic And Screening Market - TAM, US$ Billion, 2025

Table 15: Global Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Lung Cancer Diagnostic And Screening Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Lung Cancer Diagnostic And Screening Market, Sub-Segmentation Of Consumables And Accessories, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Lung Cancer Diagnostic And Screening Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Lung Cancer Diagnostic And Screening Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Lung Cancer Diagnostic And Screening Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Lung Cancer Diagnostic And Screening Market - Company Scoring Matrix

Table 97: Thermo Fisher Scientific Inc. Financial Performance

Table 98: Abbott Laboratories Inc. Financial Performance

Table 99: Danaher Corporation Financial Performance

Table 100: Siemens Healthcare GmbH Financial Performance

Table 101: FUJIFILM Corporation Financial Performance

Table 102: Global Lung Cancer Diagnostic And Screening Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Lung Cancer Diagnostic And Screening Market, Competitive Dashboard

Table 104: Global Lung Cancer Diagnostic And Screening Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Lung Cancer Diagnostic And Screening Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Table 106: Global, Lung Cancer Diagnostic And Screening Market Size Gain ($ Billion), Segmentation By Test, 2025 – 2030

Table 107: Global, Lung Cancer Diagnostic And Screening Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030

List Of Figures

Figure 1: Global Lung Cancer Diagnostic And Screening Market, Overview Of Key Products - Product Examples

Figure 2: Global Lung Cancer Diagnostic And Screening Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Lung Cancer Diagnostic And Screening Market, Supply Chain Analysis

Figure 4: Global Lung Cancer Diagnostic And Screening Market, Major Raw Material Providers

Figure 5: Global Lung Cancer Diagnostic And Screening Market, Major Resource Providers

Figure 6: Global Lung Cancer Diagnostic And Screening Market, Major Manufacturers (Suppliers)

Figure 7: Global Lung Cancer Diagnostic And Screening Market, Major Distributors And Channel Partners

Figure 8: Global Lung Cancer Diagnostic And Screening Market, Key Technologies & Future Trends

Figure 9: Global Lung Cancer Diagnostic And Screening Market, Major Trends

Figure 10: Global Lung Cancer Diagnostic And Screening Market, Major End Users

Figure 11: Global Lung Cancer Diagnostic And Screening Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Lung Cancer Diagnostic And Screening Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Lung Cancer Diagnostic And Screening Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Lung Cancer Diagnostic And Screening Market - TAM, US$ Billion, 2025

Figure 15: Global Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Lung Cancer Diagnostic And Screening Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Lung Cancer Diagnostic And Screening Market, Sub-Segmentation Of Consumables And Accessories, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Lung Cancer Diagnostic And Screening Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Lung Cancer Diagnostic And Screening Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Lung Cancer Diagnostic And Screening Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Lung Cancer Diagnostic And Screening Market - Company Scoring Matrix

Figure 97: Thermo Fisher Scientific Inc. Financial Performance

Figure 98: Abbott Laboratories Inc. Financial Performance

Figure 99: Danaher Corporation Financial Performance

Figure 100: Siemens Healthcare GmbH Financial Performance

Figure 101: FUJIFILM Corporation Financial Performance

Figure 102: Global Lung Cancer Diagnostic And Screening Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Lung Cancer Diagnostic And Screening Market, Competitive Dashboard

Figure 104: Global Lung Cancer Diagnostic And Screening Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Lung Cancer Diagnostic And Screening Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Figure 106: Global, Lung Cancer Diagnostic And Screening Market Size Gain ($ Billion), Segmentation By Test, 2025 – 2030

Figure 107: Global, Lung Cancer Diagnostic And Screening Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast ...

Respiratory Disease Testing Market Report 2026 - Global Outlook – By Test Type (Imaging Tests, Mechanical Tests, In-Vitro Diagnostic Tests), By Products (Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, Other Prod...

Lung Cancer Drugs Market Report 2026 - Global Outlook – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs ), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung canc...

Non-Small Cell Lung Cancer (NSCLC) Market Report 2026 - Global Outlook – By Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types), By Therapy (Radiotherapy, Laser Therapy, Photodynamic Therapy...

Oncology Companion Diagnostics Market Report 2026 - Global Outlook – By Product (Instrument, Consumables, Software), By Disease Type (Melanoma, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Other Disease T...

Non-Small Cell Lung Cancer (NSCLC) Market Report 2026 - Global Outlook – By Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types), By Therapy (Radiotherapy, Laser Therapy, Photodynamic Therapy...

Skin Cancer Diagnostics Market Report 2026 - Global Outlook – By Cancer Type (Basal Cell Carcinoma, Squamous Cell Carcinoma, Malignant Melanoma, Other Cancer Types), By Type (Diagnosis, Detection Solutions), By Applicati...

Frequently Asked Questions

How big is the Lung Cancer Diagnostic And Screening Market?

The Lung Cancer Diagnostic And Screening market was valued at $2.56 billion in 2025, increased to $2.8 billion in 2026, and is projected to reach $4.04 billion by 2030. request a sample here

What is the Lung Cancer Diagnostic And Screening market growth?

The global Lung Cancer Diagnostic And Screening market is expected to grow at a CAGR of 9.6% from 2026 to 2035 to reach $4.04 billion by 2035. request a sample here

Who are the key players in Lung Cancer Diagnostic And Screening market?

Some Key Players in the Lung Cancer Diagnostic And Screening market Include, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, Koninklijke Philips N.V., GE Healthcare Bio Sciences AB, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., Myriad Genetic Laboratories Inc., NeoGenomics Laboratories Inc., Canon Medical Systems Corporation, Oncimmune Holdings Plc, Riverain Technologies LLC, VisionGate, Foundation Medicine Inc., Biodesix, OncoCyte, Broncus Medical Inc. . request a sample here

What is the anticipated growth trend for the Lung Cancer Diagnostic And Screening market?

Major trend in this market includes: Blood-Based Test To Provide Accessible And Convenient Lung Cancer Screening . For further insights on this market. request a sample here

Which region has the most growth potential in the Lung Cancer Diagnostic And Screening market?

North America was the largest region in the lung cancer diagnostic and screening market in 2025. The regions covered in the lung cancer diagnostic and screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Lung Cancer Diagnostic And Screening Market Report 2026 market?

Major companies operating in the Lung Cancer Diagnostic And Screening Market Report 2026 market are Major companies operating in the lung cancer diagnostic and screening market are Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, Koninklijke Philips N.V., GE Healthcare Bio Sciences AB, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., Myriad Genetic Laboratories Inc., NeoGenomics Laboratories Inc., Canon Medical Systems Corporation, Oncimmune Holdings Plc, Riverain Technologies LLC, VisionGate, Foundation Medicine Inc., Biodesix, OncoCyte, Broncus Medical Inc. request a sample here.

Which region has the most growth potential in the Lung Cancer Diagnostic And Screening Market Report 2026 market?